Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats
- PMID: 14618237
- DOI: 10.1007/s00125-003-1262-x
Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats
Abstract
Aims/hypothesis: The renin angiotensin system is emerging as a potential therapeutic target for diabetic retinopathy. This study examines the effects of angiotensin-converting-enzyme inhibition by captopril and angiotensin AT(1) receptor antagonism using candesartan-cilexetil on retinal blood flow and acetylcholine-stimulated vasodilatation in normotensive diabetic rats.
Methods: Non-diabetic or streptozotocin-induced diabetic rats were treated for 2 weeks with captopril (100 mg/kg/day) or candesartan cilexetil (2 mg/kg/day). Retinal haemodynamics were measured using video fluorescein angiography. Effects of exogenous acetylcholine on retinal haemodynamics were examined following intravitreal injection. Total retinal diacylglycerol was labelled using diacylglycerol kinase, separated by thin-layer chromatography, and quantified using autoradiography.
Results: Diabetic rats had prolonged retinal mean circulation time and decreased retinal blood flow compared with non-diabetic rats. Treatment of diabetic rats with either captopril or candesartan blocked the development of these blood flow abnormalities. Intravitreal injection of acetylcholine (10(-5) mol/l) in non-diabetic rats increased retinal blood flow by 53.9+/-22.0% relative to baseline whereas this response to acetylcholine was blunted in diabetic rats (4.4+/-19.6%, p<0.001). Candesartan treatment of diabetic rats restored the acetylcholine-stimulated retinal blood flow response to 60.0+/-18.7% compared with a 56.2+20.1% response in candesartan-treated non-diabetic rats. Total retinal diacylglycerol levels were increased in diabetic rats (3.75+/-0.98 nmol/mg, p<0.05) compared with non-diabetic rats (2.13+/-0.25 nmol/mg) and candesartan-treatment of diabetic rats normalized diacylglycerol levels (2.10+/-0.25 nmol/mg, p<0.05).
Conclusion/interpretation: This report provides evidence that angiotensin-converting enzyme inhibition and AT(1) receptor antagonism ameliorates retinal haemodynamic dysfunctions in normotensive diabetic rats.
Similar articles
-
Gender-specific regulation of pancreatic islet blood flow, insulin levels and glycaemia in spontaneously diabetic Goto-Kakizaki rats.Clin Sci (Lond). 2008 Jul;115(1):35-42. doi: 10.1042/CS20070386. Clin Sci (Lond). 2008. PMID: 18205625
-
Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism.Eur J Pharmacol. 2005 Sep 27;520(1-3):179-87. doi: 10.1016/j.ejphar.2005.07.020. Eur J Pharmacol. 2005. PMID: 16139267
-
Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2711-20. Invest Ophthalmol Vis Sci. 1997. PMID: 9418723
-
Candesartan cilexetil: an angiotensin II receptor blocker.Ann Pharmacother. 1999 Dec;33(12):1287-98. doi: 10.1345/aph.19005. Ann Pharmacother. 1999. PMID: 10630830 Review.
-
[Pharmacological profiles of candesartan cilexetil (TCV-116)].Nihon Rinsho. 1999 May;57(5):1130-6. Nihon Rinsho. 1999. PMID: 10361446 Review. Japanese.
Cited by
-
The role of arginase I in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes.Diabetologia. 2013 Mar;56(3):654-62. doi: 10.1007/s00125-012-2789-5. Epub 2012 Dec 12. Diabetologia. 2013. PMID: 23232640 Free PMC article.
-
Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.Hypertension. 2009 Feb;53(2):175-81. doi: 10.1161/HYPERTENSIONAHA.108.117663. Epub 2009 Jan 5. Hypertension. 2009. PMID: 19124682 Free PMC article.
-
Systemic Retinaldehyde Treatment Corrects Retinal Oxidative Stress, Rod Dysfunction, and Impaired Visual Performance in Diabetic Mice.Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6294-303. doi: 10.1167/iovs.15-16990. Invest Ophthalmol Vis Sci. 2015. PMID: 26431483 Free PMC article.
-
Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms.Neurosci Bull. 2024 Mar;40(3):383-400. doi: 10.1007/s12264-023-01110-0. Epub 2023 Sep 16. Neurosci Bull. 2024. PMID: 37715924 Free PMC article. Review.
-
Candesartan Normalizes Changes in Retinal Blood Flow and p22phox in the Diabetic Rat Retina.Pathophysiology. 2021 Mar 2;28(1):86-97. doi: 10.3390/pathophysiology28010008. Pathophysiology. 2021. PMID: 35366272 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials